|
PNRC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.101800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.033800E-02 |
| Normal-vs-Stage2 |
8.052800E-01 |
| Normal-vs-Stage3 |
5.929400E-01 |
| Normal-vs-Stage4 |
3.248000E-01 |
| Stage1-vs-Stage2 |
2.358200E-01 |
| Stage1-vs-Stage3 |
3.182100E-02 |
| Stage1-vs-Stage4 |
7.092200E-02 |
| Stage2-vs-Stage3 |
5.566600E-01 |
| Stage2-vs-Stage4 |
3.805800E-01 |
| Stage3-vs-Stage4 |
8.089200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.366100E-02 |
| Normal-vs-AfricanAmerican |
6.322200E-01 |
| Normal-vs-Asian |
1.146230E-01 |
| Caucasian-vs-AfricanAmerican |
4.880000E-01 |
| Caucasian-vs-Asian |
4.905400E-01 |
| AfricanAmerican-vs-Asian |
4.726600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.378380E-02 |
| Normal-vs-Female |
5.182800E-01 |
| Male-vs-Female |
7.583700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.915400E-01 |
| Normal-vs-Extreme_Weight |
5.735900E-03 |
| Normal-vs-Obese |
9.048200E-01 |
| Normal-vs-Extreme_Obese |
1.421230E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.146650E-01 |
| Normal_Weight-vs-Obese |
3.829600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.505400E-01 |
| Extreme_Weight-vs-Obese |
5.241200E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.737400E-01 |
| Obese-vs-Extreme_Obese |
2.782200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.733000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.896400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.785900E-02 |
| Normal-vs-Age(81-100Yrs) |
1.709200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.433600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.003550E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.466010E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.833800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.953400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.453400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.535700E-02 |
| Normal-VS-Type2 PRCC |
9.838500E-02 |
| Normal-VS-KIRP CIMP |
8.964800E-03 |
| Normal-VS-Unclassified PRCC |
3.999200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.548000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.338400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.628400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.042200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.517600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.69220000000903E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.437900E-02 |
| Normal-vs-N1 |
1.080000E-01 |
| Normal-vs-N2 |
9.628400E-01 |
| N0-vs-N1 |
5.880600E-03 |
| N0-vs-N2 |
5.590400E-01 |
| N1-vs-N2 |
4.545600E-01 |
|
|
